Regeneron reports positive results for its Covid-19 treatment

The trial has found that the drug reduced Covid-19 related medical visits by 72%

The drug, called REGN-COV2 found itself in the spotlight recently after President Donald Trump was treated with the antibody cocktail. Picture: Regeneron

Biopharma company Regeneron has reported positive results for its Covid-19 treatment saying the antibody cocktail significantly reduced virus levels and the need for further medical attention.

Headquartered in New York, Regeneron has a major operations facility in Limerick and is currently adding more than 400 jobs there in order to maximise capacity at its US facility to produce large quantities of the treatment.